Showing 2 results for Rostami M
Pajoohi M, Bastan Hagh Mh, Rajab A, Masoud A, Rostami M,
Volume 58, Issue 3 (7 2000)
Abstract
Infection is one of the important causes of morbidity and mortality in diabetic patients. It has been reported that poorly controlled patients are more susceptible to infection, hence we examined the chemiluminescence of leukocytes from Insulin dependent diabetic patients in response to a soluble (Phorbol meristate acetate) and particular stimulus (Opsonized zymosan). The patients were divided into 2 separate groups, only controlled and well controlled, in regard to their blood glucose. Using PMA as a stimulus leukocytes from both groups, patients showed no significant difference comparing with healthy controls, but that of the 2 groups of patients were significantly different (P<0.05). When opsonized zymosan was used as the stimulus, no statistically significant difference was observed between all of the coupled groups. However, the chemiluminescence of leukocytes from poorly controlled patients was lower than the other groups.
Daryani E.b.n , Jafari Sepehr A.h, Tajik Rostami M, Bashasti M,
Volume 64, Issue 7 (9 2006)
Abstract
A high percent of patients with inflammatory bowel diseases (IBD) experience non intestinal symptoms. Many studies demonstrated that hepatobiliary disorders are the most common. Corresponding disorders consist of primary sclerosing cholangitis, non alcoholic steatohepatitis (NASH), biliary stones, pericholangitis, autoimmune hepatitis, liver amyloidosis, liver abscess, liver granuloma, hepatocellular carcinoma and primary biliary cirrhosis. However most studies concentrate on identifying primary sclerosing cholangitis, the most dreadful complication of IBD, other disorders like NASH and biliary stones are common and because of the similarity of symptoms to the primary disease may be ignored. In this article we review these disorders.
